Am J Psychiatry 1986; 143:1106-1112
Copyright © 1986 by American Psychiatric Association
Two-year follow-up of exposure and imipramine treatment of agoraphobia
M Mavissakalian and L Michelson
Sixty-two agoraphobic patient who had completed a controlled study of
therapist-assisted in vivo exposure (flooding) and imipramine were assessed
1 month, 6 months, 1 year, and 2 years later. Overall, improvement during
treatment was maintained throughout follow-up. At 1 month but not
subsequently, imipramine and flooding had significant effects on central
measures of agoraphobia. Patients who were marked treatment responders had
a favorable clinical course and did not experience secondary depression,
unlike patients who had not responded markedly to treatment. These findings
suggest that treatments which evoke maximum therapeutic benefit initially
are likely to foster long- term maintenance and reduce subsequent
depressive sequelae.
This article has been cited by other articles:
|
|
|
|
 
B. Milrod, A. C. Leon, F. Busch, M. Rudden, M. Schwalberg, J. Clarkin, A. Aronson, M. Singer, W. Turchin, E. T. Klass, et al.
A Randomized Controlled Clinical Trial of Psychoanalytic Psychotherapy for Panic Disorder
Focus,
October 1, 2008;
6(4):
496 - 504.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Milrod, A. C. Leon, F. Busch, M. Rudden, M. Schwalberg, J. Clarkin, A. Aronson, M. Singer, W. Turchin, E. T. Klass, et al.
A Randomized Controlled Clinical Trial of Psychoanalytic Psychotherapy for Panic Disorder
Am J Psychiatry,
February 1, 2007;
164(2):
265 - 272.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Milrod, F. Busch, A. C. Leon, A. Aronson, J. Roiphe, M. Rudden, M. Singer, T. Shapiro, H. Goldman, D. Richter, et al.
A Pilot Open Trial of Brief Psychodynamic Psychotherapy for Panic Disorder
J Psychother Pract Res.,
October 1, 2001;
10(4):
239 - 245.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
F. Lotufo-Neto, M. Bernik, R. T. Ramos, L. Andrade, C. Gorenstein, T. Cordas, M. Melo, and V. Gentil
A dose-finding and discontinuation study of clomipramine in panic disorder
J Psychopharmacol,
January 1, 2001;
15(1):
13 - 17.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. H. Barlow, J. M. Gorman, M. K. Shear, and S. W. Woods
Cognitive-Behavioral Therapy, Imipramine, or Their Combination for Panic Disorder: A Randomized Controlled Trial
JAMA,
May 17, 2000;
283(19):
2529 - 2536.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. M. Gorman, M. K. Shear, J. S. McIntyre, and D. A. Zarin
Drs. Gorman, Shear, McIntyre, and Zarin Reply
Am J Psychiatry,
December 1, 1998;
155(12):
1799 - 1800.
[Full Text]
|
|
|
|
|
|
|
L. S. Meredith, C. D. Sherbourne, C. A. Jackson, P. Camp, and K. B. Wells
Treatment Typically Provided for Comorbid Anxiety Disorders
Arch Fam Med,
May 1, 1997;
6(3):
231 - 237.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Van Dyck and P. Spinhoven
Does Preference for Iype of Treatment Matter?: A Study of Exposure In Vivo with or without Hypnosis in the Treatment of Panic Disorder with Agoraphobia
Behav Modif,
April 1, 1997;
21(2):
172 - 186.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. Schweizer, K. Rickels, S. Weiss, and S. Zavodnick
Maintenance Drug Treatment of Panic Disorder: I. Results of a Prospective, Placebo-Controlled Comparison of Alprazolam and Imipramine
Arch Gen Psychiatry,
January 1, 1993;
50(1):
51 - 60.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Rickels, E. Schweizer, S. Weiss, and S. Zavodnick
Maintenance Drug Treatment for Panic Disorder: II. Short- and Long-term Outcome After Drug Taper
Arch Gen Psychiatry,
January 1, 1993;
50(1):
61 - 68.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H.C. Middleton
Psychology and pharmacology in the treatment of anxiety disorders: co-operation or confrontation
J Psychopharmacol,
January 1, 1991;
5(4):
281 - 285.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H.C. Middleton
'Psychological inflammation'. Clarification of the model and a rejoinder
J Psychopharmacol,
January 1, 1991;
5(4):
301 - 304.
[PDF]
|
|
|
|
|
|
|
R. Noyes Jr, J. Reich, J. Christiansen, M. Suelzer, B. Pfohl, and W. A. Coryell
Outcome of Panic Disorder: Relationship to Diagnostic Subtypes and Comorbidity
Arch Gen Psychiatry,
September 1, 1990;
47(9):
809 - 818.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. S. Markowitz, M. M. Weissman, R. Ouellette, J. D. Lish, and G. L. Klerman
Quality of Life in Panic Disorder
Arch Gen Psychiatry,
November 1, 1989;
46(11):
984 - 992.
[Abstract]
[PDF]
|
|
|
|
|
|
|
L. M. Nagy, J. H. Krystal, S. W. Woods, and D. S. Charney
Clinical and Medication Outcome After Short-term Alprazolam and Behavorial Group Treatment in Panic Disorder: 2.5-Year Naturalistic Follow-up Study
Arch Gen Psychiatry,
November 1, 1989;
46(11):
993 - 999.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. C. Ballenger, G. D. Burrows, R. L. DuPont Jr, I. M. Lesser, R. Noyes Jr, J. C. Pecknold, A. Rifkin, and R. P. Swinson
Alprazolam in Panic Disorder and Agoraphobia: Results From a Multicenter Trial: I. Efficacy in Short-term Treatment
Arch Gen Psychiatry,
May 1, 1988;
45(5):
413 - 422.
[Abstract]
[PDF]
|
|
|
|
|
|
|
I. M. Lesser, R. T. Rubin, J. C. Pecknold, A. Rifkin, R. P. Swinson, R. B. Lydiard, G. D. Burrows, R. Noyes Jr, and R. L. DuPont Jr
Secondary Depression in Panic Disorder and Agoraphobia: I. Frequency, Severity, and Response to Treatment
Arch Gen Psychiatry,
May 1, 1988;
45(5):
437 - 443.
[Abstract]
[PDF]
|
|
|
Get information about faster international access.
Privacy Policy
Copyright © 1986
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|
